Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hafid Algristian has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Case Report: Post-Traumatic Stress Disorder (PTSD) with Thyrotoxicosis and Psychosocial Stress

    by Masyita Kusuma Maharani, Hafid Algristian, Ariyani Sri Suwarti

    Post-Traumatic Stress Disorder (PTSD) is a psychiatric condition triggered by trauma, often exacerbated by medical comorbidities like thyrotoxicosis. This report aims to illustrate the complex interaction between PTSD, endocrine dysfunction, and psychosocial stress, highlighting the need for an integrated treatment approach. This case report is based on a clinical case of a 31-year-old female with PTSD and comorbid thyrotoxicosis treated at a hospital in Indonesia. Data were collected through clinical history, physical and psychiatric examinations, and a review of relevant literature. The patient developed PTSD symptoms following a motorcycle accident, including nightmares, hyperarousal, insomnia, and avoidance behavior. Her pre-existing thyrotoxicosis amplified anxiety and physiological arousal, while psychosocial stressors such as legal issues and unemployment perpetuated her symptoms. A combined treatment of Sertraline 50 mg/day, short-term Alprazolam, trauma-focused therapy, and spiritual coping strategies resulted in initial improvement in anxiety and emotional regulation. Managing PTSD with comorbid thyrotoxicosis and psychosocial stress requires a biopsychosocial-endocrine approach. Coordinated pharmacological, psychotherapeutic, and psychosocial interventions are essential for symptom control and functional recovery. This case underscores the importance of multidisciplinary collaboration in complex PTSD presentations.

  • Open Access

    SPECIAL CHILDREN’S FESTIVAL: IMPLEMENTING BEHAVIORAL THERAPY THROUGH INTRODUCING JAPANESE CULTURE FOR CHILDREN WITH SPECIAL NEEDS

    by Hafid Algristian, Fifi Khoirul Fitriyah, Khamida Khamida, Ubaidillah Zuhdi, Salsadilla March Nur Huda, Aditya Bagus Heryarudra Sundoro, Khadijah Khairul Bariyah

    Children with Special Needs (CSN) in Surabaya still face limitations in conventional therapy services that tend to focus on symptom management, necessitating a more inclusive and enjoyable alternative approach. The Special Children Festival program presents an innovation through implementing Japanese culture-based behavioral therapy to improve children's emotional regulation, focus, and fine motor skills. The novelty of this activity lies in integrating cultural elements into behavioral therapy and strengthening collaboration between hospitals, universities, and the community. The activity was held on June 28, 2025, at Campus B UNUSA, involving 14 CSN and their parents, three therapists from RSI Jemursari Surabaya, one Japan Corner facilitator, and six UNUSA Medical Faculty students. The implementation method included participatory observation and feedback analysis. The intervention consisted of onigiri-making and Japanese calligraphy (shodo) sessions, preceded by education for parents about culture-based behavioral therapy. Evaluation was conducted by assessing children’s engagement, responses during the activities, and parents’ perceptions of the program’s usefulness. This activity increased CSN participation and had a positive impact on focus, emotional regulation, and fine motor skills. Promotion strategies through parent communities and digital media proved effective in participant recruitment. Service standardization through training and certification of support staff enhanced service quality and sustainability, making this program a replicable model for culture-based behavioral therapy for CSN.

  • Open Access

    Delivering Reality Therapy through Online Psychological Assistance for Healthcare workers during COVID-19 Pandemics

    by Nur Azizah A.S, Hafid Algristian, Khamida Khamida, Friska Ayu, Khadijah Khairul Bariyah

    Introduction: Indonesia faces a critical situation with 8% of its COVID-19 deaths being healthcare workers (HCWs). These workers are highly susceptible to the virus due to contact with infected patients. Approximately 35.5% of HCWs treating COVID-19 patients develop symptoms within 14 days, and 7% test positive via PCR. Alarmingly, 36% of HCWs are asymptomatic, posing a significant risk of unknowingly spreading the virus. The pandemic has induced fear of death, infection, and transmitting the virus to family members among HCWs, necessitating psychological support to prevent burnout and maintain a functional healthcare system. Objective: This study aims to analyze the effectiveness of online psychological assistance for HCWs at the forefront of the COVID-19 battle. Methods: One of the psychological assistance methods offered is through social media applications. This type of psychological assistance can be considered the most practical and safe method because it prevents transmission between medical personnel. Results: The increasing number of COVID-19 patients has increased fatigue and infection rates among HCWs. They face uncertainty and feelings of loneliness during the pandemic. However, social support is crucial for psychological first aid and recovery. Misconceptions about COVID-19 being a conspiracy hinder HCWs' efforts. Promoting healthy behaviors such as hygiene practices and mask usage can mitigate the severity of the virus and improve survival rates. Conclusions: In 2020, the surge in COVID-19 cases has forced HCWs to adapt. Nonetheless, conspiracy theories about COVID-19 complicate their duties. Implementing an online psychological assistance application is essential to provide HCWs with the psychological support needed to adapt more effectively to the pandemic's challenges.

  • Open Access

    Pharmacist Mediated Clinical Decision Support Systems: A Narrative Review of Impact and Implementation

    by Hafid Algristian, Muhammad Aji Satria

    Clinical decision support systems (CDSS) are increasingly deployed to assist pharmacists in managing complex pharmacotherapy, yet their real world effectiveness and implementation determinants remain incompletely characterised. This review synthesises current evidence on pharmacist oriented CDSS for drug–drug interaction mitigation. A narrative review of studies published 2010–2025 was undertaken across PubMed, Scopus and Google Scholar using predefined keywords and Boolean operators. Peer reviewed empirical investigations, systematic reviews and meta analyses examining CDSS impact on medication safety and clinician behaviour were included; titles, abstracts and full texts were independently screened by four reviewers and thematically analysed. Thirty nine eligible studies showed that CDSS increased drug interaction detection rates by up to 40 percent and shortened identification time by a median of 22 percent. Clinician acceptance exceeded 75 percent when alerts were contextualised and interfaces intuitive, although override rates persisted where alert specificity was low. Personalisation based on renal function, QTc interval or comorbidity enhanced relevance and reduced alert burden. Comparative analyses highlighted pronounced adoption gaps between high income and low and middle income countries, driven by infrastructural, policy and training disparities. Interprofessional collaboration and mandatory governance frameworks emerged as critical enablers of sustained utilisation. Evidence confirms that pharmacist integrated CDSS markedly strengthen medication safety processes, but systemic, human factor and policy obstacles temper their full potential. Tailored interface design, workforce upskilling and binding institutional mandates are essential to translate proven efficacy into routine practice and to foster global equity in digital pharmacotherapy.

  • Open Access

    Effectiveness of a Multimodal Therapeutic Approach for Disorganization Symptoms in Hebephrenic Schizophrenia: A Case Report

    by Affan Tsaqif Taufiqurrahman, Winaryani Winaryani, Hafid Algristian

    Hebephrenic schizophrenia, or disorganized-type schizophrenia, represents one of the most disabling and treatment-resistant subtypes of psychotic disorders, marked by disorganized thinking, affect, and behavior. These symptoms often persist despite standard pharmacological treatment and are associated with poor cognitive and social functioning. This case report explores the effectiveness of an integrated multimodal therapeutic approach that combines pharmacological, cognitive-behavioral, and metabolic strategies in managing a young woman with chronic hebephrenic schizophrenia. The patient, a 23-year-old female with a six-year illness duration and history of medication nonadherence, was treated with aripiprazole 15 mg/day (dopamine D2 partial agonist), trifluoperazine 5 mg/day (full D2 antagonist), folic acid 1 mg/day, and vitamin B6 100 mg/day. Cognitive Behavioral Therapy (CBT) and family psychoeducation were conducted twice weekly for three weeks. After treatment, she demonstrated measurable improvement, including a 1-point reduction in conceptual disorganization and a 2-point improvement in blunted affect (PANSS-R), alongside qualitative gains in coping with auditory hallucinations and affective responsiveness. These results suggest that synergistic modulation of dopaminergic circuits, cognitive restructuring, and metabolic support may yield short-term benefits for patients with treatment-resistant disorganization symptoms. Further longitudinal studies are warranted to evaluate long-term outcomes and neurobiological mechanisms.

  • Open Access

    Anhedonia is a Symptom of Severe Depression and Generalized Anxiety Disorder

    by Akhmad Vauwaz Z H, Nur Azizah, Hafid Algristian

    Anhedonia, defined as the reduced ability to experience pleasure, is a core symptom of major depressive disorder (MDD) and is increasingly recognized as a transdiagnostic marker that bridges depressive and anxiety disorders. This report presents the case of a 16-year-old Indonesian girl who exhibited pervasive sadness, irritability, fatigue, and marked anhedonia characterized by complete disengagement from competitive swimming, a central aspect of her self-identity. Psychosocial stressors, including parental conflict and academic pressure, preceded the escalation of symptoms. Clinical assessment revealed a severe depressive episode, with a Hamilton Depression Rating Scale (HDRS) score of 24 and significant anhedonia confirmed by the Snaith–Hamilton Pleasure Scale (SHAPS). Neurological and laboratory examinations were unremarkable. The patient was diagnosed with severe MDD (F32.2) and comorbid generalized anxiety disorder (F41.1) according to PPDGJ-III and DSM-5 criteria. Treatment included sertraline (up to 50 mg/day), short-term clobazam, and supportive psychotherapy with family intervention. At four-week follow-up, depressive symptoms improved, accompanied by partial recovery of motivation and social engagement. This case highlights anhedonia as a clinically prominent and functionally impairing symptom in adolescent depression and anxiety. Beyond its emotional dimension, anhedonia reflects a disruption of reward processing that contributes to poor academic, social, and developmental outcomes. Routine assessment of anhedonia using structured instruments such as SHAPS and culturally sensitive interviews may improve diagnostic precision and guide personalized treatment. Early detection and integrative interventions—combining pharmacological, psychotherapeutic, and family-based approaches—are essential for optimizing recovery and preventing long-term disability in adolescent mood disorders.

  • Open Access

    Post-Traumatic Stress Disorder as a Systemic Cascade: A Psychoneuroimmunological Systematic Review

    by Muhamad Afif Tegar, Hafid Algristian, Yekti Mumpuni

    Post-Traumatic Stress Disorder (PTSD) has traditionally been viewed as a psychiatric condition; however, emerging evidence from psychoneuroimmunology (PNI) demonstrates that PTSD involves systemic physiological dysregulation extending across neural, endocrine, cardiovascular, gastrointestinal, and immune domains. This systematic review synthesizes recent findings from studies published between 2004 and 2025 to conceptualize PTSD as a psychoneuroimmunological cascade. Literature retrieved from PubMed, Scopus, and Web of Science was analyzed thematically to identify converging mechanisms of neuroendocrine, immune, and metabolic alterations associated with PTSD. The review reveals consistent patterns of hypothalamic pituitary adrenal (HPA) axis dysfunction, autonomic overactivation, chronic inflammation, gut–microbiota imbalance, and endocrine–immune cross-talk. These interconnected processes form self-perpetuating feedback loops that translate psychological trauma into systemic disease. PTSD should therefore be reframed as a multisystem disorder sustained by psychoneuroimmunological dysregulation rather than as a purely psychological condition. Integrative, multidisciplinary interventions—combining pharmacotherapy, mind–body therapies, and lifestyle modulation—are essential to restore systemic homeostasis and improve long-term outcomes. This reconceptualization expands theoretical understanding of PTSD, bridges psychiatry with internal medicine, and informs trauma-informed clinical and policy practices.

  • Open Access

    Insomnia as a Contributor to Hypertension and Somatic Distress: A Case Report

    by Nihazzatuzzain, Hafid Algristian, Budi Cahyono

    Insomnia is increasingly recognized as a systemic disorder involving persistent hyperarousal with broad psychiatric and cardiovascular consequences. This case report describes a 49-year-old woman who developed functional dyspepsia after taking an analgesic, which led to chronic insomnia and, subsequently, essential hypertension (blood pressure reaching 173/93 mmHg) accompanied by generalized somatic distress. Her sleep pattern became non-restorative, with reduced sleep drive and dependence on hypnotics. Psychiatric evaluation revealed Nonorganic Insomnia, a Moderate Depressive Episode, and Somatization Disorder, with an Insomnia Severity Index score of 16. Her clinical course illustrates a psychophysiological cascade. Gastrointestinal distress disrupted sleep architecture, sustained sympathetic nervous system activation, and dysregulated the hypothalamic–pituitary–adrenal axis, thereby contributing to hypertension and somatic amplification. This case highlights the need to view insomnia as a systemic condition rather than an isolated symptom. Early recognition and non-pharmacological interventions—particularly Cognitive Behavioral Therapy for Insomnia (CBT-I)—may prevent long-term cardiovascular and psychiatric complications.

  • Open Access

    Hormonal Influence on Mood Dysregulation: A Case of Bipolar Disorder with Endometriosis

    by Halimatus Sakdyah, Egy Atthahirah Septina, Linda Ramadhanty Pramesta, Muhammad Ikhsan, Alsa Shafira, Endi Nurhayati, Hafid Algristian

    Bipolar disorder often coexists with gynecological conditions such as endometriosis, presenting clinical challenges due to overlapping hormonal and neuropsychiatric influences. The impact of hormonal therapy on mood stability in women with affective disorders remains underexplored. We report the case of a 30-year-old woman with bipolar II disorder, stable for nearly two years on lamotrigine, who developed mood destabilization after initiating hormonal treatment for stage III endometriosis. Sequential regimens—dienogest, norethisterone, and ethinylestradiol–levonorgestrel—were temporally associated with new or worsening mixed affective symptoms, including agitation, insomnia, irritability, and emotional lability, despite adherence to mood stabilizers. Her Hamilton Depression Rating Scale score increased from 9 to 21 within three months, with laboratory evaluation showing elevated estradiol and suppressed luteinizing hormone, supporting a hormone-related mechanism. A structured literature review (PubMed, Scopus, Google Scholar, 2000–2024) identified limited but consistent evidence that synthetic progestins may exacerbate psychiatric symptoms in mood-vulnerable populations through neuroendocrine and neurotransmitter modulation. This case underscores the importance of recognizing hormonally induced mood dysregulation in women with pre-existing psychiatric disorders and highlights the need for proactive management strategies. We recommend pre-treatment psychiatric screening, structured and longitudinal mood monitoring throughout hormonal therapy, and close interdisciplinary collaboration between gynecology and psychiatry to optimize outcomes. Integrated care approaches may reduce the risk of mood destabilization, enhance safety, and improve quality of life for women facing the dual burden of bipolar disorder and endometriosis.

  • Open Access

    Delirium in Bipolar Disorder as a Triggering Factor to Cognitive Decline: A Case Report and Neuroprogression Insight

    by Hayyunah Rohmatul Ahadiah, Lailatus Syadza, Moch Syafirul Nur Shafly, Asikah, Hafid Algristian

    Bipolar disorder is a major contributor to global disability, affecting not only mood regulation but also cognitive function, and its impact is often exacerbated by metabolic comorbidities such as type 2 diabetes mellitus, hypertension, and dyslipidemia. These comorbid conditions can lead to poorer clinical outcomes and increase the risk of neuropsychiatric complications such as delirium and cognitive impairment, which are frequently overlooked in clinical practice. This article aims to describe and analyze the case of a 31-year-old male with a history of bipolar disorder who presented with a hyperglycemic crisis and pneumonia, followed by the onset of acute delirium and subsequent cognitive decline. Through a descriptive clinical approach, the patient’s medical and psychiatric history, laboratory findings, and treatment course are reviewed to explore the complex interaction between mood disorders and metabolic dysfunction. The analysis reveals a strong link between metabolic dysregulation and worsening neuropsychiatric outcomes. This case underscores the importance of early detection and an integrated, multidisciplinary management approach to prevent long-term cognitive deterioration in patients with psychiatric disorders accompanied by metabolic conditions, offering important implications for future clinical practice.